Topical Androgen Receptor Inhibitors Market

Market Overview

Androgens are classified as male sex hormones. Androgen receptor inhibitors are used to control the production of hormones like testosterone and dihydrotestosterone. Topical androgen receptor inhibitors are applicable for treatment of excess androgen and androgen-dependent conditions. Androgen receptor inhibitors can be used by women to treat ovary syndrome, amenorrhea or acne, whereas in men it is used for the treatment of prostate cancer, androgenic alopecia and other sexual disorders. Whereas, topical androgen receptor inhibitors market can be used for acne and alopecia.

According to the National Center for Biotechnology Information (NCBI), 9.4% of the population suffers from acne worldwide. On the other hand, acne ranks 8th among the most prevalent diseases globally.

Worldwide lockdown in several countries with huge manufacturing facilities remaining close has led to a delay in the growth of global topical androgen receptor inhibitors market. Reduced hospital visits and treatment-seeking rate amid coronavirus is expected to slower global topical androgen receptor inhibitors market growth. There has been significant focus on developing COVID 19 cure among leading biopharmaceuticals causing a delay of research and development activities in global topical androgen receptor inhibitors market.

Increasing prevalence of acne is expected to increase demand for global topical androgen receptor inhibitors market during the forecast period. Changing lifestyle has led to the rise of hair loss which is expected to boost global topical androgen receptor inhibitors market demand in the coming decade. Rise of aesthetic concern among the general population will propel global topical androgen receptor inhibitors market demand. Number of products in the pipeline will lead to global topical androgen receptor inhibitors market expansion in the forecast period. Advancement in scientific technology and increasing research and development investments in global topical androgen receptor inhibitors market are the favourable scenarios.

For instance, in August 2020 U. S. Food and Drug Administration (USFDA) has approved first topical androgen receptor inhibitors named Winlevi® (clascoterone cream 1%) developed by Cosmo Pharmaceuticals for treatment of acne for patients above 12 years. Stringent regulatory requirements are expected to challenge global topical androgen receptor inhibitors market growth. Side effects like skin irritation or redness will hinder global topical androgen receptor inhibitors market growth during the forecast period.

Market Segmentation

Based on the drug	Clascoterone
Based on the indication	Acne Alopecia
Based on the distribution channel	Hospital Pharmacies Retail Pharmacies Drug Stores Online Pharmacies

Clascoterone is currently the only approved drug in global topical androgen receptor inhibitors market generating revenue. In terms of indication, acne is expected to generate higher revenue with increasing prevalence for global topical androgen receptor inhibitors market. Hospital pharmacies will have the largest share in global topical androgen receptor inhibitors market among other distribution channels. Online pharmacies segment is expected to hold significant share with the rising adoption of e-commerce in the global topical androgen receptor inhibitors market.

North America is expected to dominate the global topical androgen receptor inhibitors market with an increasing rate of development and commercialization of androgen receptor inhibitors. Europe with a higher level of aesthetic concern is expected to have a significant share followed by North America in the global topical androgen receptor inhibitors market.

Asia-Pacific is expected to observe the highest growth rate with the rising patient population and an increasing number of domestic players in the global topical androgen receptor inhibitors market. Latin America will have moderate growth as compared to other developing regions in global topical androgen receptor inhibitors market. The Middle East and Africa tend to be least lucrative for global topical androgen receptor inhibitors market with less per capita healthcare expenditure.

Some key players contributing global topical androgen receptor inhibitors market are Cosmo Pharmaceuticals, Suzhou Kintor Pharmaceuticals Inc., and others.

The report on Topical Androgen Receptor Inhibitors Market covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2015 - 2019
• Market Size & Forecast 2020 to 2030
• Supply & Demand Value Chain
• Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain
• Market Drivers and Restraints

Regional analysis for Topical Androgen Receptor Inhibitors Market includes

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

 Report on Topical Androgen Receptor Inhibitors Market highlights:

• Shifting industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size
• Recent industry trends
• Key competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

To know more about delivery timeline for this report Contact Sales